Arbe Robotics Reports Q1 2025 Loss of $9.7M in Adjusted EBITDA, Projects 2025 Revenue of $2-$5M

Reuters
20 May
Arbe Robotics Reports Q1 2025 Loss of $9.7M in Adjusted EBITDA, Projects 2025 Revenue of $2-$5M

Arbe Robotics Ltd. reported its financial results for the first quarter of 2025, ending March 31, revealing a decline in revenues to $0.04 million from $0.1 million in the same period of 2024. The company's adjusted EBITDA showed a loss of $9.7 million, compared to a loss of $8.5 million in Q1 2024. Gross profit remained negative at ($0.3) million, consistent with the prior year. Looking ahead, Arbe projects its 2025 annual revenues to range between $2 million and $5 million, with expectations for these to be more heavily weighted towards the latter part of the year. The adjusted EBITDA for the entire year 2025 is anticipated to be between ($29 million) and ($35 million). As of March 31, 2025, Arbe held $36.7 million in cash, cash equivalents, and short-term bank deposits, alongside $35.2 million in long-term bank deposits. Recent cash infusions totaling nearly $70 million highlight investor confidence in the firm's market potential. Significant operational updates include progress towards design wins with leading European OEMs, securing orders for radar systems to support advanced data collection programs. These movements are expected to contribute to high-volume 2028 passenger vehicle platforms, with revenue generation anticipated to begin in 2027. Despite short-term delays in automakers' roll-out of advanced driver assistance systems due to broader economic shifts, Arbe continues to engage with industry leaders, advancing through RFQ stages, and aims for four design-ins with automakers in 2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arbe Robotics Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: LN90578) on May 20, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10